Introduction: Early assessment of clot function identifies coagulopathies following injury. Abnormalities include a hypercoagulable state from excess thrombin generation, as well as an acquired coagulopathy. Efforts to address coagulopathy have resulted in earlier, aggressive use of plasma emphasizing 1:1 resuscitation. The purpose of this study was to describe coagulopathies in varying hemorrhagic profiles from a cohort of injured patients. Methods: All injured patients who received at least one unit of packed red blood cells (PRBC) in the first 24 hours of admission from September 2013 to May 2015 were eligible for inclusion. Group-based trajectory modeling, using volume of transfusion over time, was used to identify specific hemorrhagic phenotypes. The TEG profile of each subgroup was characterized and group features were compared. Results: Four hemorrhagic profiles were identified among 330 patients- minimal (MIN, group 1); patients with large PRBC requirements later in the hospital course (LH, group 2); massive PRBC usage (MH, group 3) and PRBC transfusion limited to shortly after injury (EH, group 4). All groups had an R-time shorter than the normal range (3.2-3.5, p = NS). Patients in Group 3 had longer K-times (1.8 vs. 1.2-1.3, p
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2mNdfE7
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Lack of standard definitions of primary and secondary (non)responders after RYGB and SG makes it impossible to compare the litera...
-
We aimed (1) to describe the characteristics of patient–ventilator asynchrony in a population of critically ill children, (2) to describe th...
-
AbstractIntroductionVascular trauma data have been submitted to the American Association for the Surgery of Trauma PROspective Observational...
-
The NCH Healthcare System launched a "virtual visit" program, enabling patients to have a telemedicine visit any time of day or ni...
-
FDA approves Elzonris for blastic plasmacytoid dendritic cell neoplasm https://www.mdedge.com/hematologynews/article/191723/rare-diseases/...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου